BioPalette
Genome Editing x Microbiome
Kobe, Japan · Founded 2017
- Headquarters
- Kobe
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- biopalette.co.jp
- Last Round
- Series ASep 2020
- Rounds
- 2
About
BioPalette is a Kobe University spinout that develops genome-edited bacteria as living medicines for microbiome-based therapeutics. Its proprietary non-cutting CRISPR base-editing technologies (Target-AID and Target-G) enable precise modification of gut microbiomes without DNA strand breaks, targeting diseases driven by microbiome dysbiosis.
Summary
BioPalette is a Biotech company based in Kobe, Japan, founded in 2017. Its most recent funding was a Series A round in Sep 2020. Investors include Jafco Ventures, UTEC - The University and Eight Roads Ventures.
Funding History
Sep 2020
Sign up to see all 2 rounds
Seed through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/biopalette"><img src="https://indexed.vc/api/badge/company/biopalette" alt="BioPalette on Indexed.vc" width="260" height="76" /></a>